title: Health economics and health technology assessment: perspectives from Australia and New Zealand.
abstract: Formal health economics and health technology assessment (HTA)processes, including cost-effectiveness and cost-utility analysis, are variably used to inform decisions about public and private health service funding and service provision. In general, pharmaceuticals have been subject to more sophisticated health economic analyses and HTAs and for a longer time than either devices or procedures. HTA has been performed by a number of different entities. While HTA shares many common features across the world, its uses, approaches, applications,and impact differ throughout the world. This article will discuss some of the general attributes of HTA and will focus on its specific applications in Australia and New Zealand.
authors: Department of Critical Care Medicine, Auckland District Health Board, 2 Park Road, Grafton, Auckland 1023, New Zealand. stephens@adhb.govt.nz
authors: Stephen
authors: S
authors: Streat
authors: Stephen
authors: S
authors: Munn
mesh_terms: D001315:Australia; D003362:Cost-Benefit Analysis; D003659:Decision Making, Organizational; D005380:Financing, Government / Q000458:organization & administration*; D015276:Health Care Rationing / Q000191:economics*; D006801:Humans; D009520:New Zealand; D004364:Pharmaceutical Preparations / Q000191:economics; D013673:Technology Assessment, Biomedical
chemical_list: D004364:Pharmaceutical Preparations